Julie M. Gastier‐Foster

ORCID: 0000-0001-7141-8031
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Acute Lymphoblastic Leukemia research
  • Cancer Genomics and Diagnostics
  • Childhood Cancer Survivors' Quality of Life
  • Chronic Myeloid Leukemia Treatments
  • Neuroblastoma Research and Treatments
  • Sarcoma Diagnosis and Treatment
  • Acute Myeloid Leukemia Research
  • Epigenetics and DNA Methylation
  • RNA modifications and cancer
  • Tumors and Oncological Cases
  • Genomic variations and chromosomal abnormalities
  • Cancer, Hypoxia, and Metabolism
  • Lymphoma Diagnosis and Treatment
  • Genomics and Rare Diseases
  • DNA Repair Mechanisms
  • Cancer therapeutics and mechanisms
  • Cancer-related molecular mechanisms research
  • Chronic Lymphocytic Leukemia Research
  • Renal and related cancers
  • Cancer-related Molecular Pathways
  • Prenatal Screening and Diagnostics
  • Genetic factors in colorectal cancer
  • Adolescent and Pediatric Healthcare
  • Molecular Biology Techniques and Applications
  • Glioma Diagnosis and Treatment

Baylor College of Medicine
2015-2025

Texas Children's Hospital
2020-2025

The Ohio State University Wexner Medical Center
2013-2024

Nationwide Children's Hospital
2014-2023

The Ohio State University
2014-2023

Children's Oncology Group
2006-2022

Arcadia
2006-2022

Van Andel Institute
2020

St. Jude Children's Research Hospital
2018-2019

National Cancer Institute
2015-2018

T J Ley Christopher A. Miller Li Ding Benjamin J. Raphael Andrew J. Mungall and 95 more Gordon L. Robertson Katherine A. Hoadley Timothy J. Triche Peter W. Laird Jack Baty Lucinda Fulton Robert S. Fulton Sharon E. Heath Joelle Kalicki-Veizer Cyriac Kandoth Jeffery M. Klco Daniel C. Koboldt Krishna Kanchi Shashikant Kulkarni Tamara Lamprecht David E. Larson Ge Lin Charles Lu Michael D. McLellan Joshua F. McMichael Jacqueline E. Payton Heather K. Schmidt David H. Spencer Michael H. Tomasson John W. Wallis Lukas D. Wartman Mark A. Watson John S. Welch Michael C. Wendl Adrian Ally Miruna Balasundaram İnanç Birol Yaron S.N. Butterfield Readman Chiu Andy Chu Eric Chuah Hye Jung E. Chun Richard Corbett Noreen Dhalla Ranabir Guin Anyuan He Carrie Hirst Martin Hirst Robert A. Holt Steven J.M. Jones Aly Karsan Darlene Lee Haiyan I. Li Marco A. Marra Michael Mayo Richard A. Moore Karen Mungall Jeremy Parker Erin Pleasance Patrick Plettner Jacquie Schein Dominik Stoll Lucas Swanson Angela Tam Nina Thiessen Richard Varhol Natasja Wye Yongjun Zhao Stacey Gabriel Gad Getz Carrie Sougnez Lihua Zou Mark D.M. Leiserson Fabio Vandin Hsin Ta Wu Frederick R. Applebaum Stephen B. Baylin Rehan Akbani Bradley M. Broom Ken Chen Thomas Motter Khanh Cong Nguyen John N. Weinstein Nianziang Zhang Martin L. Ferguson Christopher M. Adams Aaron Black Jay Bowen Julie M. Gastier‐Foster Thomas W. Grossman Tara M. Lichtenberg Lisa Wise Tanja M. Davidsen John A. Demchok Kenna Shaw Margi Sheth Heidi J. Sofia Liming Yang James R. Downing Greg Eley

Many mutations that contribute to the pathogenesis of acute myeloid leukemia (AML) are undefined. The relationships between patterns and epigenetic phenotypes not yet clear. We analyzed genomes 200 clinically annotated adult cases de novo AML, using either whole-genome sequencing (50 cases) or whole-exome (150 cases), along with RNA microRNA DNA-methylation analysis. AML have fewer than most other cancers, an average only 13 found in genes. Of these, 5 genes recurrently mutated AML. A total...

10.1056/nejmoa1301689 article EN New England Journal of Medicine 2013-05-02
Daniel J. Brat Roel G.W. Verhaak Kenneth D. Aldape W. K. Alfred Yung Sofie R. Salama and 95 more Lee Cooper Esther Rheinbay C. Ryan Miller Mark Vitucci Olena Morozova A. Gordon Robertson Houtan Noushmehr Peter W. Laird Andrew D. Cherniack Rehan Akbani Jason T. Huse Giovanni Ciriello Laila Poisson Jill S. Barnholtz‐Sloan Mitchel S. Berger Cameron Brennan Rivka R. Colen Howard Colman Adam E. Flanders Caterina Giannini Mia Grifford Antonio Iavarone Rajan Jain Isaac Joseph Jaegil Kim L. Sylvia Tom Mikkelsen Bradley A. Murray Brian Patrick O’Neill Lior Pachter D. Williams Parsons Carrie Sougnez Erik P. Sulman Scott R. VandenBerg Erwin G. Van Meir Andreas von Deimling Hailei Zhang Daniel Crain Kevin Lau David Mallery Scott Morris Joseph Paulauskis Robert Penny Troy Shelton Mark E. Sherman Peggy Yena Aaron Black Jay Bowen Katie Dicostanzo Julie M. Gastier‐Foster Kristen Leraas Tara M. Lichtenberg Christopher R. Pierson Nilsa C. Ramirez Cynthia Taylor Stephanie Weaver Lisa Wise Erik Zmuda Tanja M. Davidsen John A. Demchok Greg Eley Martin L. Ferguson Carolyn M. Hutter Kenna Shaw Bradley A. Ozenberger Margi Sheth Heidi J. Sofia Roy Tarnuzzer Linghua Wang Liming Yang Jean C. Zenklusen Brenda Ayala Julien Baboud Sudha Chudamani Mark A. Jensen Jia Liu Todd Pihl Rohini Raman Yunhu Wan Ye Wu Adrian Ally J. Todd Auman Miruna Balasundaram Saianand Balu Stephen B. Baylin Rameen Beroukhim Arnoud Boot Reanne Bowlby Christopher A. Bristow Denise Brooks Yaron S.N. Butterfield Rebecca Carlsen Scott L. Carter Lynda Chin Andy Chu

Diffuse low-grade and intermediate-grade gliomas (which together make up the lower-grade gliomas, World Health Organization grades II III) have highly variable clinical behavior that is not adequately predicted on basis of histologic class. Some are indolent; others quickly progress to glioblastoma. The uncertainty compounded by interobserver variability in diagnosis. Mutations IDH, TP53, ATRX codeletion chromosome arms 1p 19q (1p/19q codeletion) been implicated as clinically relevant...

10.1056/nejmoa1402121 article EN New England Journal of Medicine 2015-06-11
Adrian Ally Miruna Balasundaram Rebecca Carlsen Eric Chuah Amanda Clarke and 95 more Noreen Dhalla Robert A. Holt Steven J.M. Jones Darlene Lee Yussanne Ma Marco A. Marra Michael Mayo Richard A. Moore Andrew J. Mungall Jacqueline E. Schein Payal Sipahimalani Angela Tam Nina Thiessen Dorothy Cheung Tina Wong Denise Brooks A. Gordon Robertson Reanne Bowlby Karen Mungall Sara Sadeghi Xi Liu Kyle Covington Eve Shinbrot David A. Wheeler Richard A. Gibbs Lawrence A. Donehower Linghua Wang Jay Bowen Julie M. Gastier‐Foster Mark Gerken Carmen Helsel Kristen Leraas Tara M. Lichtenberg Nilsa C. Ramirez Lisa Wise Erik Zmuda Stacey Gabriel Matthew Meyerson Carrie Cibulskis Bradley A. Murray Juliann Shih Rameen Beroukhim Andrew D. Cherniack Steven E. Schumacher Gordon Saksena Chandra Sekhar Pedamallu Lynda Chin Gad Getz Michael S. Noble Hailei Zhang David I. Heiman Juok Cho Nils Gehlenborg Gordon Saksena Douglas Voet Pei Lin Scott Frazer Timothy Defreitas Thomas J. Giordano Michael S. Lawrence Jaegil Kim Chad J. Creighton Donna M. Muzny HarshaVardhan Doddapaneni Hai Hu Min Wang Donna Morton Viktoriya Korchina Yi Han Huyen Dinh Lora Lewis Michelle Bellair Xiuping Liu Jireh Santibanez Robert Glenn Charles Lee Walker Hale Joel S. Parker Matthew D. Wilkerson D. Neil Hayes Sheila M. Reynolds Ilya Shmulevich Wei Zhang Yuexin Liu Lisa Iype Hala R. Makhlouf Michael Torbenson Sanjay Kakar Matthew M. Yeh Dhanpat Jain David E. Kleiner Dhanpat Jain Renumathy Dhanasekaran Hashem B. El‐Serag Sun Young Yim

Liver cancer has the second highest worldwide mortality rate and limited therapeutic options. We analyzed 363 hepatocellular carcinoma (HCC) cases by whole-exome sequencing DNA copy number analyses, we 196 HCC methylation, RNA, miRNA, proteomic expression also. mutation analysis identified significantly mutated genes, including LZTR1, EEF1A1, SF3B1, SMARCA4. Significant alterations or downregulation hypermethylation in genes likely to result metabolic reprogramming (ALB, APOB, CPS1) were...

10.1016/j.cell.2017.05.046 article EN cc-by-nc-nd Cell 2017-06-01
A. Gordon Robertson Jaegil Kim Hikmat Al‐Ahmadie Joaquim Bellmunt Guangwu Guo and 95 more Andrew D. Cherniack Toshinori Hinoue Peter W. Laird Katherine A. Hoadley Rehan Akbani Mauro A. A. Castro Ewan A. Gibb Rupa S. Kanchi Dmitry A. Gordenin Sachet A. Shukla Francisco Sánchez-Vega Donna E. Hansel Bogdan Czerniak Victor E. Reuter Xiaoping Su Benílton de Sá Carvalho Vinicius S Chagas Karen Mungall Sara Sadeghi Chandra Sekhar Pedamallu Yiling Lu Leszek J. Klimczak Jiexin Zhang Caleb Choo Akinyemi I. Ojesina Susan Bullman Kristen Leraas Tara M. Lichtenberg Catherine J. Wu N. Schultz Gad Getz Matthew Meyerson Gordon B. Mills David J. McConkey John N. Weinstein David J. Kwiatkowski Seth P. Lerner Rehan Akbani Hikmat Al‐Ahmadie Monique Albert Iakovina Alexopoulou Adrian Ally Tatjana Antic Manju Aron Miruna Balasundaram John M.S. Bartlett Stephen B. Baylin Allison Beaver Joaquim Bellmunt İnanç Birol Lori Boice Arnoud Boot Jay Bowen Reanne Bowlby Denise Brooks Bradley M. Broom Wiam Bshara Susan Bullman Eric Burks Flavio Mavignier Cárcano Rebecca Carlsen Benilton S. Carvalho André Lopes Carvalho Eric Castle Mauro A. A. Castro Mauro A. A. Castro James W.F. Catto Vinicius S Chagas Andrew D. Cherniack David Chesla Caleb Choo Eric Chuah Sudha Chudamani Victoria K. Cortessis Sandra Cottingham Daniel Crain Erin Curley Bogdan Czerniak Siamak Daneshmand John A. Demchok Noreen Dhalla Hooman Djaladat John Eckman Sophie Egea Jay Engel Ina Felau Martin L. Ferguson Johanna Gardner Julie M. Gastier‐Foster Mark Gerken Gad Getz Ewan A. Gibb Carmen Gomez‐Fernandez Dmitry A. Gordenin Guangwu Guo

10.1016/j.cell.2017.09.007 article EN publisher-specific-oa Cell 2017-10-01
Benjamin J. Raphael Ralph H. Hruban Andrew J. Aguirre Richard A. Moffitt Jen Jen Yeh and 95 more Chip Stewart A. Gordon Robertson Andrew D. Cherniack Manaswi Gupta Gad Getz Stacey Gabriel Matthew Meyerson Carrie Cibulskis Suzanne S. Fei Toshinori Hinoue Hui Shen Peter W. Laird Shiyun Ling Yiling Lu Gordon B. Mills Rehan Akbani Phillipe Loher Eric Londin Isidore Rigoutsos Aristeidis G. Telonis Ewan A. Gibb Anna Goldenberg Aziz M. Mezlini Katherine A. Hoadley Eric A. Collisson Eric S. Lander Bradley A. Murray Julian M. Hess Mara Rosenberg Louis Bergelson Hailei Zhang Juok Cho Grace Tiao Jaegil Kim Dimitri Livitz Ignaty Leshchiner Brendan Reardon Eliezer M. Van Allen Atanas Kamburov Rameen Beroukhim Gordon Saksena Steven E. Schumacher Michael S. Noble David I. Heiman Nils Gehlenborg Jaegil Kim Michael S. Lawrence Volkan Adsay Gloria M. Petersen David S. Klimstra Nabeel Bardeesy Mark D.M. Leiserson Reanne Bowlby L. Sylvia İnanç Birol Karen Mungall Sara Sadeghi John N. Weinstein Paul T. Spellman Yuexin Liu Laufey T. Ámundadóttir Joel E. Tepper Aatur D. Singhi Rajiv Dhir Paul Drwiega Thomas C. Smyrk Lizhi Zhang Paula Kim Jay Bowen Jessica Frick Julie M. Gastier‐Foster Mark Gerken Kevin Lau Kristen Leraas Tara M. Lichtenberg Nilsa C. Ramirez Jeremy Renkel Mark E. Sherman Lisa Wise Peggy Yena Erik Zmuda Juliann Shih Adrian Ally Miruna Balasundaram Rebecca Carlsen Andy Chu Eric Chuah Amanda Clarke Noreen Dhalla Robert A. Holt Steven J.M. Jones Darlene Lee Yussanne Ma Marco A. Marra Michael Mayo

10.1016/j.ccell.2017.07.007 article EN cc-by-nc-nd Cancer Cell 2017-08-01
A. Gordon Robertson Juliann Shih Christina Yau Ewan A. Gibb Junna Oba and 95 more Karen Mungall Julian M. Hess Vladislav Uzunangelov Vonn Walter Ludmila Danilova Tara M. Lichtenberg Melanie H. Kucherlapati Patrick K. Kimes Ming Tang Alexander Penson Özgün Babur Rehan Akbani Christopher A. Bristow Katherine A. Hoadley Lisa Iype Matthew T. Chang Andrew D. Cherniack Christopher C. Benz Gordon B. Mills Roel G.W. Verhaak Klaus Griewank Ina Felau Jean C. Zenklusen Hui Shen Lynn Schoenfield Alexander J. Lazar Mohamed H. Abdel‐Rahman Sergio Román-Román Marc‐Henri Stern Colleen M. Cebulla Michelle D. Williams Martine J. Jager Sarah E. Coupland Bita Esmaeli Cyriac Kandoth Scott E. Woodman Mohamed H. Abdel‐Rahman Rehan Akbani Adrian Ally J. Todd Auman Özgün Babur Miruna Balasundaram Saianand Balu Christopher C. Benz Rameen Beroukhim İnanç Birol Tom Bodenheimer Jay Bowen Reanne Bowlby Christopher A. Bristow Denise Brooks Rebecca Carlsen Colleen M. Cebulla Matthew T. Chang Andrew D. Cherniack Lynda Chin Juok Cho Eric Chuah Sudha Chudamani Carrie Cibulskis Kristian Cibulskis Leslie Cope Sarah E. Coupland Ludmila Danilova Timothy Defreitas John A. Demchok Laurence Desjardins Noreen Dhalla Bita Esmaeli Ina Felau Martin L. Ferguson Scott Frazer Stacey Gabriel Julie M. Gastier‐Foster Nils Gehlenborg Mark Gerken Hui Shen Gad Getz Ewan A. Gibb Klaus Griewank Elizabeth A. Grimm D. Neil Hayes Apurva M. Hegde David I. Heiman Carmen Helsel Julian M. Hess Katherine A. Hoadley Shital Hobensack Robert A. Holt Alan P. Hoyle Xin Hu Carolyn M. Hutter Martine J. Jager Joshua M. Stuart Corbin D. Jones

10.1016/j.ccell.2017.07.003 article EN cc-by-nc-nd Cancer Cell 2017-08-01
Lauren Fishbein Ignaty Leshchiner Vonn Walter Ludmila Danilova A. Gordon Robertson and 95 more Amy R. Johnson Tara M. Lichtenberg Bradley A. Murray Hans K. Ghayee Tobias Else Shiyun Ling Joshua M. Stuart Aguirre A. de Cubas Brandon M. Wenz Esther Korpershoek Antonio L. Amelio Liza Makowski W. Kimryn Rathmell Anne‐Paule Gimenez‐Roqueplo Thomas J. Giordano L. Sylvia Arthur S. Tischler Karel Pacák Katherine L. Nathanson Matthew D. Wilkerson Rehan Akbani Adrian Ally Laurence Amar Antonio L. Amelio Harindra Arachchi L. Sylvia Richard J. Auchus J. Todd Auman Robert Baertsch Miruna Balasundaram Saianand Balu Detlef K. Bartsch Éric Baudin Thomas Bauer Allison Beaver Christopher C. Benz Rameen Beroukhim Felix Beuschlein Tom Bodenheimer Lori Boice Jay Bowen Reanne Bowlby Denise Brooks Rebecca Carlsen Suzie Carter Clarissa A. Cassol Andrew D. Cherniack Lynda Chin Juok Cho Eric Chuah Sudha Chudamani Leslie Cope Daniel Crain Erin Curley Ludmila Danilova Aguirre A. de Cubas Ronald R. de Krijger John A. Demchok Timo Deutschbein Noreen Dhalla David Dimmock Winand N.M. Dinjens Tobias Else Charis Eng Jennifer Eschbacher Martin Faßnacht Ina Felau Michael D. Feldman Martin L. Ferguson Ian T. Fiddes Lauren Fishbein Scott Frazer Stacey Gabriel Johanna Gardner Julie M. Gastier‐Foster Nils Gehlenborg Mark Gerken Gad Getz Jennifer L. Geurts Hans K. Ghayee Anne‐Paule Gimenez‐Roqueplo Thomas J. Giordano Mary J. Goldman Kiley Graim Manaswi Gupta David Haan Stefanie Hahner Constanze Hantel David Haussler D. Neil Hayes David I. Heiman Katherine A. Hoadley Robert A. Holt Alan P. Hoyle Mei Huang

10.1016/j.ccell.2017.01.001 article EN publisher-specific-oa Cancer Cell 2017-02-01

10.1016/j.ccell.2017.02.010 article EN Cancer Cell 2017-03-01

Survival for children and young adults with high-risk B-acute lymphoblastic leukemia has improved significantly, but 20% to 25% of patients are not cured. Children's Oncology Group study AALL0232 tested two interventions improve survival.Between January 2004 2011, enrolled 3,154 participants 1 30 years old newly diagnosed leukemia. By using a 2 × factorial design, 2,914 were randomly assigned receive dexamethasone (14 days) versus prednisone (28 during induction high-dose methotrexate...

10.1200/jco.2015.62.4544 article EN Journal of Clinical Oncology 2016-04-26

Abstract There is incomplete understanding of genetic heterogeneity and clonal evolution during cancer progression. Here we use deep whole-exome sequencing to describe the architecture 20 pediatric B-acute lymphoblastic leukaemias from diagnosis relapse. We show that diversity comparable at relapse survival not associated with mutation burden. Six pathways were frequently mutated, NT5C2 , CREBBP WHSC1 TP53 USH2A NRAS IKZF1 mutations enriched Half had multiple subclonal in a pathway or gene...

10.1038/ncomms7604 article EN cc-by Nature Communications 2015-03-19
Milan Radovich Curtis R. Pickering Ina Felau Gavin Ha Hailei Zhang and 95 more Heejoon Jo Katherine A. Hoadley Pavana Anur Jiexin Zhang Michael D. McLellan Reanne Bowlby Thomas Matthew Ludmila Danilova Apurva M. Hegde Jaegil Kim Mark D.M. Leiserson Geetika Sethi Charles Lu Michael Ryan Xiaoping Su Andrew D. Cherniack Gordon Robertson Rehan Akbani Paul T. Spellman John N. Weinstein D. Neil Hayes Benjamin J. Raphael Tara M. Lichtenberg Kristen Leraas Jean C. Zenklusen Junya Fujimoto Cristovam Scapulatempo‐Neto André L. Moreira David Hwang James Huang Mirella Marino Robert J. Korst Giuseppe Giaccone Yesim Gökmen–Polar Sunil Badve Arun Rajan Philipp Ströbel Nicolas Girard Ming‐Sound Tsao Alexander Marx Anne S. Tsao Patrick J. Loehrer Adrian Ally Elizabeth L. Appelbaum J. Todd Auman Miruna Balasundaram Saianand Balu Madhusmita Behera Rameen Beroukhim Mario Berríos Giovanni Blandino Tom Bodenheimer Arnoud Boot Jay Bowen Denise Brooks Flavio Mavignier Cárcano Rebecca Carlsen André Lopes Carvalho Mauro A. A. Castro Lara Chalabreysse Lynda Chin Juok Cho Gina Choe Eric Chuah Sudha Chudamani Carrie Cibulskis Leslie Cope Matthew G. Cordes Daniel Crain Erin Curley Timothy Defreitas John A. Demchok Frank Detterbeck Noreen Dhalla Hendrik Dienemann W. Jeff Edenfield Francesco Facciolo Martin L. Ferguson Scott Frazer Catrina C. Fronick Lucinda A. Fulton Robert S. Fulton Stacey Gabriel Johanna Gardner Julie M. Gastier‐Foster Nils Gehlenborg Mark Gerken Gad Getz David I. Heiman Shital Hobensack Andrea Holbrook Robert A. Holt Alan P. Hoyle Carolyn M. Hutter Michael Ittmann

Highlights•Multi-omics definition of four robust molecular TET subtypes associated with survival•Thymomas have the lowest mutational burden among adult cancers•Enrichment HRAS, NRAS, TP53, and recurrent GTF2I mutations are observed•Expression autoimmune targets aneuploidy links thymoma to myasthenia gravisSummaryThymic epithelial tumors (TETs) one rarest malignancies. Among TETs, is most predominant, characterized by a unique association diseases, followed thymic carcinoma, which less common...

10.1016/j.ccell.2018.01.003 article EN cc-by-nc-nd Cancer Cell 2018-02-01

Treatment planning for children with neuroblastoma requires accurate assessment of prognosis. The most recent Children's Oncology Group (COG) risk classification system used tumor stage as defined by the International Neuroblastoma Staging System. Here, we validate a revised classifier using Risk System (INRGSS) and incorporate segmental chromosome aberrations (SCA) an additional genomic biomarker.

10.1200/jco.21.00278 article EN Journal of Clinical Oncology 2021-07-28

Background Rhabdomyosarcoma (RMS) is divided into two major histological subtypes: alveolar (ARMS) and embryonal (ERMS), with most ARMS expressing one of oncogenic genes fusing PAX3 or PAX7 FOXO1 (P3F P7F, respectively). The Children's Oncology Group (COG) carried out a multi-institutional clinical trial to evaluate the prognostic value PAX-FOXO1 fusion status. Methods Study participants were treated on COG protocol D9803 for intermediate risk ERMS using multi-agent chemotherapy,...

10.1002/pbc.24532 article EN Pediatric Blood & Cancer 2013-03-22
Coming Soon ...